Dietary arginine prevents atherogenesis in the coronary artery of the hypercholesterolemic rabbit
BY Wang,
AH Singer,
PS Tsao,
H Drexler,
J Kosek,
and
JP Cooke
Division of Cardiovascular Medicine, Stanford University School of Medicine, California 94305.
OBJECTIVES. This study was designed to test the hypothesis that long-term oral supplementation of dietary L-arginine (to provide a sustained elevation of nitric oxide activity) would inhibit atherogenesis in hypercholesterolemic rabbits, as assessed by histomorphometric measurements. BACKGROUND. Endothelium-derived nitric oxide inhibits a number of processes that are critical in atherogenesis. Hypercholesterolemia reduces endothelial nitric oxide activity, and we postulate that this may promote atherogenesis. This reduction in nitric oxide activity can be reversed acutely by intravenous infusion of L-arginine, the precursor of nitric oxide. We show that dietary supplementation of L-arginine abrogates the development of coronary atheroma in hypercholesterolemic rabbits. METHODS. Male New Zealand White rabbits were fed normal rabbit chow, 1% cholesterol chow or 1% cholesterol chow with dietary arginine or methionine supplementation to increase their intake of these amino acids sixfold. After 1 or 10 weeks of dietary intervention, the left main and left anterior descending coronary arteries were harvested for histologic study. Plasma cholesterol measurements were elevated to the same degree in all groups of rabbits receiving the 1% cholesterol diet, whereas plasma arginine levels were doubled in the arginine-treated group. High density lipoprotein (HDL) cholesterol values were not affected by arginine treatment. RESULTS. In rabbits receiving the 1% cholesterol diet, with or without methionine supplementation, light and electron microscopy revealed a marked increase from 1 to 10 weeks in the intimal accumulation of macrophages, associated with an increase in the intimal area of the left main coronary artery. By contrast, in arginine-treated hypercholesterolemic rabbits, there was a near absence of adherent monocytes and tissue macrophages and no progression of intimal thickness from 1 to 10 weeks. CONCLUSIONS. Dietary supplements of L-arginine prevent intimal thickening in the coronary arteries of hypercholesterolemic rabbits. This antiatherogenic effect is not due to an alteration in plasma total cholesterol, HDL cholesterol or caloric or nitrogen balance. The data are consistent with the hypothesis that nitric oxide has antiatherogenic properties.
This article has been cited by other articles:

|
 |

|
 |
 
A. I. Saleh, S. M. Abdel Maksoud, S. A. El-Maraghy, and M. Z. Gad
Protective Effect of L-Arginine in Experimentally Induced Myocardial Ischemia: Comparison With Aspirin
Journal of Cardiovascular Pharmacology and Therapeutics,
March 1, 2011;
16(1):
53 - 62.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
W.H. W. Tang, Z. Wang, L. Cho, D. M. Brennan, and S. L. Hazen
Diminished Global Arginine Bioavailability and Increased Arginine Catabolism as Metabolic Profile of Increased Cardiovascular Risk
J. Am. Coll. Cardiol.,
June 2, 2009;
53(22):
2061 - 2067.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Wesseling, M. P. Koeners, and J. A. Joles
Taurine: Red Bull or Red Herring?
Hypertension,
June 1, 2009;
53(6):
909 - 911.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Hayashi, P. A. R. Juliet, H. Matsui-Hirai, A. Miyazaki, A. Fukatsu, J. Funami, A. Iguchi, and L. J. Ignarro
L-citrulline and L-arginine supplementation retards the progression of high-cholesterol-diet-induced atherosclerosis in rabbits
PNAS,
September 20, 2005;
102(38):
13681 - 13686.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Voisine, C. Bianchi, T. A. Khan, M. Ruel, S.-H. Xu, J. Feng, J. Li, T. Malik, A. Rosinberg, and F. W. Sellke
Normalization of coronary microvascular reactivity and improvement in myocardial perfusion by surgical vascular endothelial growth factor therapy combined with oral supplementation of L-arginine in a porcine model of endothelial dysfunction
J. Thorac. Cardiovasc. Surg.,
June 1, 2005;
129(6):
1414 - 1420.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Paddon-Jones, E. Borsheim, and R. R. Wolfe
Potential Ergogenic Effects of Arginine and Creatine Supplementation
J. Nutr.,
October 1, 2004;
134(10):
2888S - 2894S.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Niebauer, A. J. Maxwell, P. S. Lin, D. Wang, P. S. Tsao, and J. P. Cooke
NOS inhibition accelerates atherogenesis: reversal by exercise
Am J Physiol Heart Circ Physiol,
July 11, 2003;
285(2):
H535 - H540.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Kalinowski, H. Alfke, S. Bergen, K. J. Klose, J. J. Barry, and H.-J. Wagner
Comparative Trial of Local Pharmacotherapy with L-Arginine, r-Hirudin, and Molsidomine to Reduce Restenosis after Balloon Angioplasty of Stenotic Rabbit Iliac Arteries
Radiology,
June 1, 2001;
219(3):
716 - 723.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. H. Boger, S. M. Bode-Boger, P. S. Tsao, P. S. Lin, J. R. Chan, and J. P. Cooke
An endogenous inhibitor of nitric oxide synthase regulates endothelial adhesiveness for monocytes
J. Am. Coll. Cardiol.,
December 1, 2000;
36(7):
2287 - 2295.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Ishigami, D. K. Swertfeger, M. S. Hui, N. A. Granholm, and D. Y. Hui
Apolipoprotein E Inhibition of Vascular Smooth Muscle Cell Proliferation but Not the Inhibition of Migration Is Mediated Through Activation of Inducible Nitric Oxide Synthase
Arterioscler Thromb Vasc Biol,
April 1, 2000;
20(4):
1020 - 1026.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. R. Chan, R. H. Boger, S. M. Bode-Boger, O. Tangphao, P. S. Tsao, T. F. Blaschke, and J. P. Cooke
Asymmetric Dimethylarginine Increases Mononuclear Cell Adhesiveness in Hypercholesterolemic Humans
Arterioscler Thromb Vasc Biol,
April 1, 2000;
20(4):
1040 - 1046.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. J Maxwell, B. E Anderson, and J. P Cooke
Nutritional therapy for peripheral arterial disease: a double-blind, placebo-controlled, randomized trial of HeartBar(R)
Vascular Medicine,
February 1, 2000;
5(1):
11 - 19.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
S. J. Hutchison, K. Sudhir, R. E. Sievers, B.-Q. Zhu, Y.-P. Sun, T. M. Chou, K. Chatterjee, P. C. Deedwania, J. P. Cooke, S. A. Glantz, et al.
Effects of L-Arginine on Atherogenesis and Endothelial Dysfunction due to Secondhand Smoke
Hypertension,
July 1, 1999;
34(1):
44 - 50.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. A. D. Nascimento, K. Kauser, and G. M. Rubanyi
Effect of 17beta -estradiol in hypercholesterolemic rabbits with severe endothelial dysfunction
Am J Physiol Heart Circ Physiol,
May 1, 1999;
276(5):
H1788 - H1794.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Miyazaki, H. Matsuoka, J. P. Cooke, M. Usui, S. Ueda, S. Okuda, and T. Imaizumi
Endogenous Nitric Oxide Synthase Inhibitor : A Novel Marker of Atherosclerosis
Circulation,
March 9, 1999;
99(9):
1141 - 1146.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. E. Brousseau and J. M. Hoeg
Transgenic rabbits as models for atherosclerosis research
J. Lipid Res.,
March 1, 1999;
40(3):
365 - 375.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
M. Barton, C. C. Haudenschild, L. V. d'Uscio, S. Shaw, K. Munter, and T. F. Luscher
Endothelin ETA receptor blockade restores NO-mediated endothelial function and inhibits atherosclerosis in apolipoprotein E-deficient mice
PNAS,
November 24, 1998;
95(24):
14367 - 14372.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Corseaux, T. Le Tourneau, I. Six, M. D. Ezekowitz, E. P. Mc Fadden, T. Meurice, P. Asseman, C. Bauters, and B. Jude
Enhanced Monocyte Tissue Factor Response After Experimental Balloon Angioplasty in Hypercholesterolemic Rabbit: Inhibition With Dietary L-Arginine
Circulation,
October 27, 1998;
98(17):
1776 - 1782.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Guo, V. Andres, and K. Walsh
Nitric Oxide Induced Downregulation of Cdk2 Activity and Cyclin A Gene Transcription in Vascular Smooth Muscle Cells
Circulation,
May 26, 1998;
97(20):
2066 - 2072.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Van Belle, C. Bauters, T. Asahara, and J. M. Isner
Endothelial regrowth after arterial injury: from vascular repair to therapeutics
Cardiovasc Res,
April 1, 1998;
38(1):
54 - 68.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Kojda, B. Husgen, A. Hacker, D. Perings, E. M. Schnaith, E. Kottenberg, and E. Noack
Impairment of endothelium-dependent vasorelaxation in experimental atherosclerosis is dependent on gender
Cardiovasc Res,
March 1, 1998;
37(3):
738 - 747.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. L. Baldwin, L. M. Wilson, I. Gradus-Pizlo, R. Wilensky, and K. March
Effect of Atherosclerosis on Transmural Convection and Arterial Ultrastructure : Implications for Local Intravascular Drug Delivery
Arterioscler Thromb Vasc Biol,
December 1, 1997;
17(12):
3365 - 3375.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
J. Niebauer, R. Hambrecht, T. Velich, K. Hauer, C. Marburger, B. Kalberer, C. Weiss, E. von Hodenberg, G. Schlierf, G. Schuler, et al.
Attenuated Progression of Coronary Artery Disease After 6 Years of Multifactorial Risk Intervention : Role of Physical Exercise
Circulation,
October 21, 1997;
96(8):
2534 - 2541.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
S. J. Hutchison, M. S. Reitz, K. Sudhir, R. E. Sievers, B.-Q. Zhu, Y.-P. Sun, T. M. Chou, P. C. Deedwania, K. Chatterjee, S. A. Glantz, et al.
Chronic Dietary L-Arginine Prevents Endothelial Dysfunction Secondary to Environmental Tobacco Smoke in Normocholesterolemic Rabbits
Hypertension,
May 1, 1997;
29(5):
1186 - 1191.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
S. P. Schwarzacher, T. T. Lim, B. Wang, R. S. Kernoff, J. Niebauer, J. P. Cooke, and A. C. Yeung
Local Intramural Delivery of L-Arginine Enhances Nitric Oxide Generation and Inhibits Lesion Formation After Balloon Angioplasty
Circulation,
April 1, 1997;
95(7):
1863 - 1869.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
U. Ikeda, K. Yamamoto, Y. Maeda, M. Shimpo, T. Kanbe, and K. Shimada
Endothelin-1 Inhibits Nitric Oxide Synthesis in Vascular Smooth Muscle Cells
Hypertension,
January 1, 1997;
29(1):
65 - 69.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
X.-F. Niu, G. Ibbotson, and P. Kubes
A Balance Between Nitric Oxide and Oxidants Regulates Mast Cell Dependent Neutrophil Endothelial Cell Interactions
Circ. Res.,
November 1, 1996;
79(5):
992 - 999.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
P. S. Tsao, R. Buitrago, J. R. Chan, and J. P. Cooke
Fluid Flow Inhibits Endothelial Adhesiveness: Nitric Oxide and Transcriptional Regulation of VCAM-1
Circulation,
October 1, 1996;
94(7):
1682 - 1689.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
R. W. Jeremy, H. McCarron, and D. Sullivan
Effects of Dietary L-Arginine on Atherosclerosis and Endothelium-Dependent Vasodilatationin the Hypercholesterolemic Rabbit: Response According to Treatment Duration, Anatomic Site, and Sex
Circulation,
August 1, 1996;
94(3):
498 - 506.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
R. C. Candipan, B.-y. Wang, R. Buitrago, P. S. Tsao, and J. P. Cooke
Regression or Progression : Dependency on Vascular Nitric Oxide
Arterioscler Thromb Vasc Biol,
January 1, 1996;
16(1):
44 - 50.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
P. S. Tsao, N. P. Lewis, S. Alpert, and J. P. Cooke
Exposure to Shear Stress Alters Endothelial Adhesiveness : Role of Nitric Oxide
Circulation,
December 15, 1995;
92(12):
3513 - 3519.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
M. E. Russell, A. F. Wallace, L. R. Wyner, J. B. Newell, and M. J. Karnovsky
Upregulation and Modulation of Inducible Nitric Oxide Synthase in Rat Cardiac Allografts With Chronic Rejection and Transplant Arteriosclerosis
Circulation,
August 1, 1995;
92(3):
457 - 464.
[Abstract]
[Full Text]
|
 |
|
|